Literature DB >> 35483734

Endothelin Receptor Antagonists for Kidney Protection: Lessons from the SONAR Trial.

Hiddo J L Heerspink1, Dick de Zeeuw2.   

Abstract

Entities:  

Keywords:  clinical trial; diabetic nephropathy; endothelin receptor antagonists

Mesh：

Substances：

Year:  2022        PMID： 35483734      PMCID： PMC9269667          DOI： 10.2215/CJN.00560122

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  11 in total

1.  Predictors of congestive heart failure after treatment with an endothelin receptor antagonist.

Authors:  Jamo Hoekman; Hiddo J Lambers Heerspink; Giancarlo Viberti; Damien Green; Johannes F E Mann; Dick de Zeeuw
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 8.237

2.  SONAR: Do a New Design and Statistically Significant Results Translate to Reliability?

Authors:  Michael Walsh
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-04       Impact factor: 8.237

3.  Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.

Authors:  Hiddo J L Heerspink; Tom Greene; Hocine Tighiouart; Ron T Gansevoort; Josef Coresh; Andrew L Simon; Tak Mao Chan; Fan Fan Hou; Julia B Lewis; Francesco Locatelli; Manuel Praga; Francesco Paolo Schena; Andrew S Levey; Lesley A Inker
Journal:  Lancet Diabetes Endocrinol       Date:  2019-01-08       Impact factor: 32.069

4.  Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Authors:  Hiddo J L Heerspink; Hans-Henrik Parving; Dennis L Andress; George Bakris; Ricardo Correa-Rotter; Fan-Fan Hou; Dalane W Kitzman; Donald Kohan; Hirofumi Makino; John J V McMurray; Joel Z Melnick; Michael G Miller; Pablo E Pergola; Vlado Perkovic; Sheldon Tobe; Tingting Yi; Melissa Wigderson; Dick de Zeeuw
Journal:  Lancet       Date:  2019-04-14       Impact factor: 79.321

5.  The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Randomized Trial.

Authors:  Simke W Waijer; Ron T Gansevoort; George L Bakris; Ricardo Correa-Rotter; Fan-Fan Hou; Donald E Kohan; Dalane W Kitzman; Hirofumi Makino; John J V McMurray; Vlado Perkovic; Sheldon Tobe; Hans-Henrik Parving; Dick de Zeeuw; Hiddo J L Heerspink
Journal:  Clin J Am Soc Nephrol       Date:  2021-12-01       Impact factor: 8.237

6.  Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial.

Authors:  Hiddo J L Heerspink; Di Xie; George Bakris; Ricardo Correa-Rotter; Fan-Fan Hou; Dalane W Kitzman; Donald Kohan; Hirofumi Makino; John J V McMurray; Vlado Perkovic; Peter Rossing; Hans-Henrik Parving; Dick de Zeeuw
Journal:  J Am Soc Nephrol       Date:  2021-09-22       Impact factor: 10.121

7.  Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial.

Authors:  Simke W Waijer; Sieta T de Vries; Robert Busch; Di Xie; Ron T Gansevoort; Fan Fan Hou; Jose L Górriz; Gozewijn D Laverman; Luca De Nicola; Julio Pascual; Michele Provenzano; Pablo E Pergola; Sydney C W Tang; Christoph Wanner; Philippe Zaoui; Hans-Henrik Parving; Dick de Zeeuw; Hiddo J L Heerspink
Journal:  J Am Soc Nephrol       Date:  2021-08-20       Impact factor: 10.121

8.  Avosentan reduces albumin excretion in diabetics with macroalbuminuria.

Authors:  René R Wenzel; Thomas Littke; Susan Kuranoff; Christiane Jürgens; Heike Bruck; Eberhard Ritz; Thomas Philipp; Anna Mitchell
Journal:  J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 10.121

9.  The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.

Authors:  Dick de Zeeuw; Blai Coll; Dennis Andress; John J Brennan; Hui Tang; Mark Houser; Ricardo Correa-Rotter; Donald Kohan; Hiddo J Lambers Heerspink; Hirofumi Makino; Vlado Perkovic; Yili Pritchett; Giuseppe Remuzzi; Sheldon W Tobe; Robert Toto; Giancarlo Viberti; Hans-Henrik Parving
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

Review 10.  Endothelin and endothelin antagonists in chronic kidney disease.

Authors:  Donald E Kohan; Matthias Barton
Journal:  Kidney Int       Date:  2014-05-07       Impact factor: 10.612
View more
  1 in total

Review 1.  Circadian clocks of the kidney: function, mechanism, and regulation.

Authors:  Hannah M Costello; Jermaine G Johnston; Alexandria Juffre; G Ryan Crislip; Michelle L Gumz
Journal:  Physiol Rev       Date:  2022-05-16       Impact factor: 46.500
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.